Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

TNFRSF19 / TRADE antibody

Antigen

TNFRSF19 / TRADE

Clonality Polyclonal
Host
Alternatives

Rabbit

Reactivity
Alternatives

Human, Mouse (Murine)

Application
Alternatives Western Blotting (WB)
2 references available
Catalog no. ABIN123477
Quantity 0.1 mg  (0.5 mg/ml)  (Variants)
Price 341.00 $   Plus shipping costs $45.00
Shipping to
Availability Will be delivered in 6 to 8 Business Days

Additional Information

Alternative name
UniProt Q9NS68
Immunogen Mixture of synthetic peptides corresponding to amino acids 29-44, 204-219, and 409-421 of human TROY
Cross-Reactivity Human, Mouse (Murine)
Description Analysis of EST clones and use of a signal sequence trap screening of the murine brain have lead to identification of a new member of the tumor necrosis factor receptor superfamily designated as TAJ and TROY, respectively (2,3). TAJ/TROY is a membrane protein of 423 amino acids with characteristic cysteine-rich motifs in the extracellular domain and a tumor necrosis factor receptor-associated factor (TRAF) 2 binding sequence in the cytoplasmic domain. Human TROY has 78% identity at the amino acid level with mouse TROY. The extracellular domain of TROY has significant homology with that of EDAR (another newly identified receptor belonging to TNF receptor family) that specifies hair follicle fate (1). The cytoplasmic domain of TAJ is different than other TNF receptor family members. Although its cytoplasmic domain does not contain death domain, TAJ/TROY induced cell death is probably mediated through a caspase- independent pathway. TAJ-induced JNK activation was not blocked by dominant-negative inhibitors of TRAF2, TRAF5, or ASK1, which have been previously implicated in JNK activation via TNFR1 and CD40. However, coimmunoprecipitation assays revealed that TAJ is capable of binding a number of different TRAF family members, and it is possible that TAJ-induced JNKactivation is mediated by an as yet untested TRAF homolog, such as TRAF6. TROY mRNA is highly expressed in brain, prostate and embryo and moderately expressed in the heart, lung, liver.

Application Details

Application Notes Western blot: 0.5 - 2.0 ug/ml. Recommended positive control: T98G. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Concentration 0.5 mg/ml
Purification Purified
Buffer PBS containing 0.02% sodium azide
Storage Store the antibody at 2 - 8 °C up to six months or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing. Shelf Life: one year from despatch.
Restrictions For Research Use only

Publications

Monreal, Ferguson, Headon et al.: "Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia." in: Nature genetics, Vol. 22, Issue 4, pp. 366-9, 1999 (PubMed).

Kojima, Morikawa, Copeland et al.: "TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with Edar and is expressed in embryonic skin and hair follicles." in: The Journal of biological chemistry, Vol. 275, Issue 27, pp. 20742-7, 2000 (PubMed).

Alternatives

Alternatives for antigen "TNFRSF19 / TRADE", type "Antibodies"
Hosts Rabbit (1)
Reactivities Human (1), Mouse (Murine) (1)
Applications Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (1), Western Blotting (WB) (1)